Literature DB >> 3904654

Effectiveness of potassium chloride or triamterene in thiazide hypokalemia.

V Papademetriou, J Burris, S Kukich, E D Freis.   

Abstract

Potassium chloride was compared with triamterene in a crossover trial involving 16 hypertensive patients with overt diuretic-induced hypokalemia. Potassium chloride, 24 to 96 mEq/day, normalized the plasma potassium (PK) level at 3.5 mEq/L or more in only eight of the patients. The average increase in PK level was 0.58 mEq/L. Triamterene, 50 to 200 mg daily, normalized PK level in ten of the patients. The average increase in PK level was 0.72 mEq/L, which was not significantly different than that with potassium therapy. Some patients who responded to potassium did not respond to triamterene, and vice versa. Most of the administered potassium was excreted in the urine even with persisting hypokalemia. Addition of triamterene to diuretic therapy resulted in a small but statistically significant increase in plasma creatinine level.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3904654

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

1.  Comparison of the diuretic effect and absorption of a single dose of furosemide and free and the fixed combinations of furosemide and triamterene in healthy male adults.

Authors:  J J van Meyel; Y Tan; P Smits; F G Russel; C A van Ginneken; F W Gribnau
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Diuretics in the elderly: how safe?

Authors:  W J MacLennan
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-04

3.  Adequacy of twice daily dosing with potassium chloride and spironolactone in thiazide treated hypertensive patients.

Authors:  J M Toner; L A Brawn; W W Yeo; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

4.  Tailoring antihypertensive drug therapy for the black patient.

Authors:  J Arradondo
Journal:  J Natl Med Assoc       Date:  1987-02       Impact factor: 1.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.